Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

Cell
Joseph R MazzulliDimitri Krainc

Abstract

Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known. Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degradation, causes accumulation of α-synuclein (α-syn), and results in neurotoxicity through aggregation-dependent mechanisms. Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified α-syn by stabilizing soluble oligomeric intermediates. We further demonstrate that α-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies. These findings suggest that the bidirectional effect of α-syn and GCase forms a positive feedback loop that may lead to a self-propagating disease. Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.

References

Oct 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·R E Lee
May 1, 1974·Genetics·S Brenner
Sep 1, 1996·QJM : Monthly Journal of the Association of Physicians·O NeudorferA Zimran
Jan 29, 2000·Human Mutation·D L StoneE Sidransky
Mar 10, 2001·American Journal of Medical Genetics·J K ParkE Sidransky
Aug 18, 2001·Molecular Genetics and Metabolism·N TayebiE Sidransky
Aug 6, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·John MarshallSeng H Cheng
Sep 5, 2002·Annals of Neurology·John E DudaJohn Q Trojanowski
Nov 14, 2002·Neurotoxicology·John Q Trojanowski, Virginia M Y Lee
Oct 28, 2003·The American Journal of Pathology·You-Hai XuGregory A Grabowski
Jan 16, 2004·The Journal of Biological Chemistry·Michael B TropakDon Mahuran
Jul 6, 2004·Molecular Genetics and Metabolism·Kondi WongRaphael Schiffmann
Dec 14, 2004·Journal of Medical Genetics·O Goker-AlpanE Sidransky
Mar 23, 2005·Molecular Genetics and Metabolism·Ellen Sidransky
Nov 5, 2005·Cell·Sreeganga ChandraThomas C Südhof
Sep 29, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joseph R MazzulliHarry Ischiropoulos
Jan 27, 2007·Biochemistry·Zak MartinezAnthony L Fink
Sep 6, 2007·The Journal of Biological Chemistry·Joseph R MazzulliHarry Ischiropoulos
Jan 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shusei HamamichiGuy A Caldwell
Dec 20, 2008·Lancet·Gregory A Grabowski
Feb 10, 2009·Methods in Enzymology·Susmita Kaushik, Ana Maria Cuervo
Mar 17, 2009·Brain : a Journal of Neurology·Juliane NeumannNicholas W Wood
Oct 23, 2009·The New England Journal of Medicine·E SidranskyS G Ziegler
Feb 24, 2010·Journal of Inherited Metabolic Disease·Gilberto BultronPramod K Mistry
Mar 6, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Elpida TsikaJoseph R Mazzulli
Jan 25, 2011·Molecular Genetics and Metabolism·Y H XuG A Grabowski
Apr 22, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Philip SeiblerDimitri Krainc

❮ Previous
Next ❯

Citations

Apr 17, 2013·JAMA Neurology·Michael A NallsEllen Sidransky
Jun 30, 2012·Acta Neuropathologica·Darius Ebrahimi-FakhariPamela J McLean
Sep 13, 2012·Journal of Inherited Metabolic Disease·M J BarrettG M Pastores
Jul 3, 2013·Current Neurology and Neuroscience Reports·Matthew Swan, Rachel Saunders-Pullman
Sep 1, 2012·Molecular Neurobiology·Toru YasudaHideki Mochizuki
Sep 4, 2012·Molecular Neurobiology·Maria XilouriLeonidas Stefanis
Nov 28, 2013·Molecular Neurobiology·Massimo AureliSandro Sonnino
Mar 10, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paige M DexterGuy A Caldwell
Mar 13, 2014·Biochimica Et Biophysica Acta·Hila ZigdonAnthony H Futerman
Sep 17, 2013·Neuropharmacology·J L BadgerR Wade-Martins
Dec 29, 2013·Trends in Biochemical Sciences·Han-Ming Shen, Noboru Mizushima
Feb 1, 2013·Journal of Medicinal Chemistry·Robert E BoydKenneth J Valenzano
Oct 25, 2011·Nature Reviews. Cancer·Michael J DevineNicholas W Wood
Apr 24, 2013·Nature Reviews. Molecular Cell Biology·Carmine SettembreAndrea Ballabio
Jun 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Benjamin DehayErwan Bezard
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Leelamma M PanickerRicardo A Feldman
Apr 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mickael DecressacAnders Björklund
Nov 22, 2011·Antioxidants & Redox Signaling·Patricia Boya
Oct 21, 2011·Human Molecular Genetics·Patricia Gómez-SuagaSabine Hilfiker
May 31, 2012·Human Molecular Genetics·Marija UsenovicDimitri Krainc
Dec 21, 2012·Human Molecular Genetics·Gali MaorMia Horowitz
Oct 31, 2012·Current Opinion in Hematology·Derralynn A Hughes, Gregory M Pastores
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Christine Klein, Ana Westenberger
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Leonidas Stefanis
Aug 26, 2011·Science Translational Medicine·Gregory A Petsko
Nov 8, 2012·International Journal of Alzheimer's Disease·Michela Deleidi, Walter Maetzler
Feb 1, 2012·Orphanet Journal of Rare Diseases·Tessa N Campbell, Francis Y M Choy
Sep 12, 2013·Orphanet Journal of Rare Diseases·Gali MaorMia Horowitz
Sep 29, 2011·Disease Models & Mechanisms·Tamar Farfel-BeckerAnthony H Futerman
Aug 13, 2013·PloS One·Alisdair McNeillAnthony H V Schapira
May 31, 2013·Endocrine Journal·Junji FujikuraKazuwa Nakao
Mar 24, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marija UsenovicDimitri Krainc

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.